Opportunistic mammography screening by the Brazilian Unified Health System in 2019

Abstract

Introduction: Mammography screening has been the best method for detecting early tumors and reducing breast cancer mortality according to different studies. In Brazil, the number of women who undergo mammography tests by the Brazilian Unified Health System (SUS) has been far below international recommendations. Objective: To describe the number of mammographies, mammography coverage, and the amount spent on this exam during 2019 by SUS, in Brazil. Method: Ecological study with data from the Department of Informatics of the Brazilian Unified Health System and the Brazilian Institute for Geography and Statistics in order to verify the number of mammographies performed by the SUS concerning the Brazilian female population in Brazil, in the age group of 50 to 69 years, in the states and in macro-regions during 2019. Results: In 2019, 2,660,469 mammographies were performed in the country out of the expected total of 12,154,979, accounting for a 21.9% mammography coverage by SUS at the cost of BRL 117,841,231.97. The lowest coverage rates were verified in the states of Amapá (0.6%) and the Federal District (4.9%), whereas the best rates were found in the states of Paraná (29.7%) and Alagoas (29.6%). Conclusions: The number of mammographies performed in Brazil in 2019 by SUS corresponded to almost ¼ of the country’s need, with mammography coverage far below the target and being widely different among the many Brazilian states

The COVID-19 pandemic and the increase in mortality of cancer patients in Brazil

“…The number of mammograms performed by the SUS in 2020 decreased by more than 40%, reaching a 67% reduction in Rondônia, a state in the North of the country [32]. We highlight that this region, which in 2019 already had the worst mammography coverage by the SUS in Brazil [33], showed the most signi cant increase in mortality from female breast cancer in 2022. Also, the situation remained unfavorable in 2021: 15% fewer exams than in 2019 in Brazil [34].…”

Análise do parque tecnológico do Brasil para o rastreamento do câncer de mama

“…Quanto aos exames, concluímos que as MMGs aprovadas no SUS não atingiram a meta de 50% de alcance da PA ED, corroborando os resultados encontrados para 2019 por Freitas-Junior et al ( 2020) e dos apurados de 2008 a 2017 por Rodrigues et al (2019), apesar de ambos os estudos terem calculado seus resultados com base nos parâmetros SUS vigentes à época (Freitas-Junior et al, 2020;Rodrigues et al, 2019).…”

Mortalidade por câncer de boca e faringe no Brasil entre 2008 e 2019: estudo descritivo

“…5,9,14 A explicação básica para esse achado deve-se especialmente aos aspectos comportamentais, ou seja, exposição precoce dos homens ao tabagismo e etilismo, principais fatores de risco para tal neoplasia. 14,17,24,25 Ademais, a Pesquisa Nacional de Saúde, de 2019, 26 aponta consumo masculino de tabaco de 15,9%, quase o dobro do feminino (9,6%). Outro elemento preocupante é a menor prática de autocuidado em relação a saúde entre os homens, com uma procura de serviços odontológicos cerca de 20% inferior ao sexo feminino, o que retardaria o diagnóstico.…”